• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Alcon Inc (NY: ALC )

    90.80 +0.79 (+0.88%)
    Official Closing Price Updated: 4:10 PM EDT, Jul 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 667,080
    Open 90.79
    Bid (Size) 89.30 (1)
    Ask (Size) 92.23 (1)
    Prev. Close 90.01
    Today's Range 90.00 - 90.93
    52wk Range 69.44 - 92.65
    Shares Outstanding 489,219,355
    Dividend Yield 0.26%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
    Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2? 
    Via Benzinga
    Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance
    From Alcon Inc. Investors
    Via Business Wire

    Performance

    YTD
    +17.86%
    +17.86%
    1 Month
    +1.89%
    +1.89%
    3 Month
    +12.64%
    +12.64%
    6 Month
    +14.85%
    +14.85%
    1 Year
    +8.69%
    +8.69%

    More News

    Read More
    ALC Stock Earnings: Alcon Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Do You Have Your Eye On Vision Care Stocks?
    Via Talk Markets
    MicroStrategy Was The Best Among These 10 Large-Cap Stocks Scoring Big Last Week (May 12-May 19, 2024): Are They In Your Portfolio?
    Via Benzinga
    Alcon Analysts Increase Their Forecasts Following Q1 Results
    Via Benzinga
    Alcon Inc. (NYSE: ALC) Records 52-Week High Tuesday Morning
    Via Investor Brand Network
    Contact Lens Maker Alcon's Has New Growth Avenues, Analyst Upgrades Stock
    Via Benzinga
    Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    2 Intriguing Medical Stocks To Buy For Steady Growth As Earnings Approach
    Via Talk Markets
    Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
    From Alcon Inc. Investors
    Via Business Wire
    Alcon Announces Results of 2024 Annual General Meeting
    From Alcon Inc. Investors
    Via Business Wire
    What 6 Analyst Ratings Have To Say About Alcon
    Via Benzinga
    Star Surgical Shines as U.S. Outlook Improves for 2024
    Via MarketBeat
    Alcon Publishes Agenda for 2024 Annual General Meeting
    From Alcon Inc. Investors
    Via Business Wire
    Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone
    From Alcon Inc. Corporate
    Via Business Wire
    Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
    From Alcon Inc. Investors
    Via Business Wire
    Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month
    Via Benzinga
    Buy This Ophthalmology Stock But Sell This One, Says Bernstein Analyst: 'Innovation Is Key'
    Via Benzinga
    Good News For Dry Eye Disease Patients: Eye Care Focused Alcon's Treatment Shows Encouraging Benefit In Late-Stage Trials
    Via Benzinga
    Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye
    From Alcon Inc. Investors
    Via Business Wire
    Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
    From Lifecore Biomedical, Inc.
    Via GlobeNewswire
    Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference
    From Alcon Inc. Investors
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.